Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Intravitreal Ranibizumab on Retinal Hard Exudate in Diabetic Macular Edema

(2015) Amitha Domalpally et al.   OPHTHALMOLOGY

Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema

(2015) Hemal Mehta et al.   Therapeutic Advances in Chronic Disease

A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema

(2014) Mark C. Gillies et al.   OPHTHALMOLOGY

THE PEARL NECKLACE SIGN

(2014) Susan K. Gelman et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Diabetic macular edema: new concepts in patho-physiology and treatment

(2014) Xinyuan Zhang et al.   Cell and Bioscience

Prospective Study of Inflammatory Biomarkers and Risk of Diabetic Retinopathy in the Diabetes Control and Complications Trial

(2013) Rajeev H. Muni et al.   JAMA Ophthalmology

Inflammation in diabetic retinopathy

(2011) Johnny Tang et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial

(2010) Mark C Gillies et al.   CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial

(2008) Jörgen Larsson et al.   ACTA OPHTHALMOLOGICA